Aeluma Sacrifices Government Revenue to Chase AI Datacom Customers, Widens Losses as It Races to Commercialize Indium-Phosphide Alternative
Q4 and fiscal year 2026 earnings call, September 16, 2026
Aeluma used its fiscal fourth-quarter call to lay out a deliberate pivot away from the government-funded R&D revenue that has sustained the company since inception, betting instead that commercial photonics contracts tied to the AI data center buildout will be worth the near-term sacrifice. The company is developing photodetectors and quantum dot lasers built on non-indium phosphide substrates, positioning its technology as a fix for what it describes as a structural bottleneck in indium phosphide supply that is constraining the broader optical components industry.
Government Funding Becomes Equity, Not Revenue
The most consequential disclosure on the call involved the mechanics of Aeluma's letter of intent with the Department of Commerce CHIPS R&D Office for up to $30 million. CFO Christopher Stewart told analysts that based on the LOI and precedent from other CHIPS Act deals, the award is likely to be structured as a U.S. government equity investment in Aeluma rather than recognized as contract revenue. That is a meaningful distinction for a company that has historically leaned on government contracts to fund development. Stewart was careful to frame it as still additive to the growth story, but the accounting treatment means investors should not expect this capital to show up on the income statement, even though it directly supports development of the company's high-speed photodetectors. Management also signaled that going forward it will be far more selective about which government programs it pursues. Klamkin was explicit that this could mean giving up near-term contract revenue: "This may mean sacrificing near-term government contract revenue to focus resources toward achieving commercial revenue and growth opportunities, which is what matters in generating long-term shareholder value." Booked government revenue for fiscal 2027 stands at just $2.3 million, with a further $2 million of opportunities still under discussion, a sharp step down from the $4.5 million recognized in fiscal 2026 and roughly flat with fiscal 2025's $4.7 million.
Multiple NRE Deals in Negotiation, All Tied to AI Datacom
Klamkin disclosed that Aeluma is negotiating several multimillion-dollar non-recurring engineering agreements with commercial customers, and confirmed under analyst questioning that these discussions are "almost entirely" concentrated in the AI datacom market in the near term. He attributed the urgency to a widening gap between current investment in indium phosphide manufacturing capacity and where demand forecasts are heading for 2028 through 2030 and beyond: "What we're seeing is that our customers... come from the fact that there are investments being made to sort of fill the gap in the near term, but investments being made are not going to be sufficient for that market a few years out." No dollar figures or timing were provided, and management declined to issue formal fiscal 2027 revenue guidance, citing the binary nature of a handful of contracts that could swing results materially.
Photodetectors, Not Just Lasers, Are the Underappreciated Opportunity
Much of the industry narrative around the optics bottleneck centers on laser supply, but Klamkin pushed back on the idea that photodetectors are a secondary consideration for Aeluma, calling them "the forgotten technology." The company is developing two photodetector lines: the Lynx S Series, targeting a few gigabits per second up to 64 gigabits per second for slow-and-wide scale-up interconnects, and the Lynx F Series, aimed at 200 and eventually 400 gigabits per second per lane for scale-out interconnects. Klamkin declined to size the relative opportunity between photodetectors and the company's Quasar quantum dot lasers, saying only that "they're both very significant" and that Aeluma is resourcing both rather than picking a lane. On the laser side, he pointed to reliability and packaging simplification, including the potential to eliminate the optical isolator, as differentiators beyond simply avoiding indium phosphide substrate constraints.
Manufacturing Scale-Up: Sumitomo Deal and AIXTRON Reactors
To back the commercialization push, Aeluma signed an expanded agreement with Sumitomo Chemical Advanced Technologies to increase epitaxy wafer production capacity using existing MOCVD tooling, with an initial focus on high-speed photodetectors for AI datacom. Separately, the company is procuring multiple AIXTRON G10 MOCVD systems, the same class of tools already used by Tier 1 photonics manufacturers, which Aeluma says it has reconfigured to run its proprietary non-indium phosphide substrate processes. Stewart characterized fiscal 2027 capital expenditures of $10 million to $12 million as largely tied to these two reactors and described it as a one-time step-up rather than a departure from the company's capital-light model, though he declined to guide beyond fiscal 2027.
Financial Results Show Widening Losses Alongside Cash Build
Fiscal 2026 revenue came in at $4.5 million, near the high end of prior guidance but essentially flat year over year. The cost of the commercialization push showed up clearly in profitability: GAAP net loss for the year widened to $9.2 million, or $0.52 per share, from $3 million, or $0.23 per share, in fiscal 2025. Adjusted EBITDA swung to negative $5.2 million from positive $186,000 a year earlier, driven by headcount growth and higher operating expenses. The balance sheet remains a relative strength, with $56 million in cash and no debt at quarter-end, up from $37.8 million at the end of the March quarter and $15.7 million a year ago, aided by $20.1 million in net proceeds from ATM share issuance during the fourth quarter at an average price of $24.87.
Headcount More Than Doubles With Senior Hires From Lumileds and Intel
Aeluma grew from 14 employees as of June 30, 2025 to more than 30 today, with plans for further hiring. Notable additions include Brendan Moran as VP of Engineering, who previously led mobile photonics product strategy at Lumileds on a business generating $300 million in annual revenue, and Jason Taylor, a nearly three-decade program management veteran of Intel, Kyocera and Lumileds, who is now building out formal program management infrastructure. The company also added Primit Parikh, former VP and GM of the gallium nitride business at Renesas and co-founder of Transphorm, as a strategic adviser. These hires reflect a company trying to professionalize execution as it moves from R&D-stage photonics developer toward a manufacturing-scale supplier, though the step-up in headcount is also the direct driver of the year's expense growth.